Fennec Pharmaceuticals Inc banner

Wall St Price Targets

RV41 Price Forecast
Based on 7 analysts

+52% Upside
from €8.75 today

Fennec Pharmaceuticals Inc (RV41)’s 12-month stock price forecast through October 2027 has a consensus target of €13.27, implying 52% upside. The forecast is based on price targets from 7 Wall Street analysts.

RV41 Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for RV41 yet.

Fennec Pharmaceuticals Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RV41's stock price target?
Price Target
13.27 EUR

According to Wall Street analysts, the average 1-year price target for RV41 is 13.27 EUR with a low forecast of 11.68 EUR and a high forecast of 15.18 EUR.

What is the Revenue forecast for Fennec Pharmaceuticals Inc?
Projected CAGR
24%

The compound annual growth rate for Revenue over the next 8 years is 24%.

What is the Gross Profit forecast for Fennec Pharmaceuticals Inc?
Projected CAGR
24%

The compound annual growth rate for Gross Profit over the next 8 years is 24%.

Back to Top